CN117679478A - Traditional Chinese medicine for treating diabetes - Google Patents
Traditional Chinese medicine for treating diabetes Download PDFInfo
- Publication number
- CN117679478A CN117679478A CN202311533259.8A CN202311533259A CN117679478A CN 117679478 A CN117679478 A CN 117679478A CN 202311533259 A CN202311533259 A CN 202311533259A CN 117679478 A CN117679478 A CN 117679478A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- traditional chinese
- treating diabetes
- ginseng
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 28
- 206010012601 diabetes mellitus Diseases 0.000 title claims abstract description 20
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 8
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 8
- 244000197580 Poria cocos Species 0.000 claims abstract description 8
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 8
- 235000008434 ginseng Nutrition 0.000 claims abstract description 8
- 241000213006 Angelica dahurica Species 0.000 claims abstract description 7
- 241001061264 Astragalus Species 0.000 claims abstract description 7
- 235000002722 Dioscorea batatas Nutrition 0.000 claims abstract description 7
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims abstract description 7
- 240000001811 Dioscorea oppositifolia Species 0.000 claims abstract description 7
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims abstract description 7
- 244000302512 Momordica charantia Species 0.000 claims abstract description 7
- 235000009811 Momordica charantia Nutrition 0.000 claims abstract description 7
- 235000009812 Momordica cochinchinensis Nutrition 0.000 claims abstract description 7
- 235000018365 Momordica dioica Nutrition 0.000 claims abstract description 7
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 claims abstract description 7
- 235000006533 astragalus Nutrition 0.000 claims abstract description 7
- 210000004233 talus Anatomy 0.000 claims abstract description 7
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 6
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 6
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 6
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 6
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 6
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 6
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 6
- 240000000171 Crataegus monogyna Species 0.000 claims abstract description 6
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 6
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 6
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 6
- 241000287828 Gallus gallus Species 0.000 claims abstract description 6
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 6
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 6
- 229940079593 drug Drugs 0.000 claims abstract description 3
- 244000131316 Panax pseudoginseng Species 0.000 claims abstract 3
- 235000013399 edible fruits Nutrition 0.000 claims description 4
- 239000012528 membrane Substances 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 3
- 239000008280 blood Substances 0.000 description 16
- 210000004369 blood Anatomy 0.000 description 16
- 239000006187 pill Substances 0.000 description 9
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 8
- 230000001737 promoting effect Effects 0.000 description 8
- 241000208340 Araliaceae Species 0.000 description 5
- 230000009286 beneficial effect Effects 0.000 description 5
- 230000001105 regulatory effect Effects 0.000 description 5
- 102000004877 Insulin Human genes 0.000 description 4
- 108090001061 Insulin Proteins 0.000 description 4
- 229940125396 insulin Drugs 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 230000035764 nutrition Effects 0.000 description 4
- 230000001575 pathological effect Effects 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- 239000009636 Huang Qi Substances 0.000 description 2
- 206010022489 Insulin Resistance Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 206010039424 Salivary hypersecretion Diseases 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 210000003038 endothelium Anatomy 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000000171 quenching effect Effects 0.000 description 2
- 208000026451 salivation Diseases 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 241000282461 Canis lupus Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010023379 Ketoacidosis Diseases 0.000 description 1
- 208000007976 Ketosis Diseases 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010061481 Renal injury Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000009693 chronic damage Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 230000006020 chronic inflammation Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000003345 hyperglycaemic effect Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000004153 islets of langerhan Anatomy 0.000 description 1
- 208000037806 kidney injury Diseases 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000000968 medical method and process Methods 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 239000005022 packaging material Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 208000022530 polyphagia Diseases 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 238000009827 uniform distribution Methods 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 208000016261 weight loss Diseases 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to the field of medicines, in particular to a traditional Chinese medicine for treating diabetes, which comprises chicken's gizzard-skin, rhizoma anemarrhenae, balsam pear, poria cocos, chinese angelica, hawthorn, chinese yam, malt, kudzuvine root, ginseng, astragalus and rhizoma polygonati.
Description
Technical Field
The invention relates to the field of medicines, in particular to a traditional Chinese medicine for treating diabetes.
Background
Diabetes is a ubiquitous disease that constitutes a major threat to human health. It is a chronic hyperglycemic condition, resulting from insufficient insulin secretion or dysfunction of insulin, resulting in abnormal in vivo sugar, protein and fat metabolism. Patients often have symptoms of diuresis, polydipsia, polyphagia, weight loss and the like, and chronic damage to tissues such as eyes, kidneys, nervous systems, hearts, blood vessels and the like can be caused when the patients are serious, and even acute metabolic disorders such as ketoacidosis, hypertonic coma and the like can be developed. At present, although the traditional Chinese and western medical methods for treating diabetes are various, the treatment effect is not satisfactory due to the restriction of various factors. Therefore, development of new drugs for treating diabetes is urgently required.
Disclosure of Invention
The invention aims to provide a traditional Chinese medicine for treating diabetes, which aims to solve the problems in the background technology.
In order to achieve the above purpose, the present invention provides the following technical solutions:
a Chinese medicine for treating diabetes comprises endothelium corneum Gigeriae Galli, rhizoma anemarrhenae, fructus Momordicae Charantiae, poria, radix Angelicae sinensis, fructus crataegi, rhizoma Dioscoreae, fructus Hordei Germinatus, radix Puerariae, ginseng radix, radix astragali and rhizoma Polygonati.
The medicine comprises the following components in percentage by weight:
6-20 parts of chicken's gizzard-membrane
12-24 parts of rhizoma anemarrhenae
120-180 parts of balsam pear
Poria cocos 20-30 parts
12-24 parts of Chinese angelica
Hawthorn fruit 18-24 parts
30-60 parts of Chinese yam
Malt 20-30 parts
20-30 parts of kudzuvine root
6-18 parts of ginseng
18-60 parts of astragalus
18-30 parts of rhizoma polygonati.
Compared with the prior art, the invention has the beneficial effects that:
the traditional Chinese medicine formula has the advantages that the traditional Chinese medicine formula is considered to have the potential of reducing blood sugar, is beneficial to maintaining the blood sugar level in a normal range, is considered to be capable of improving the sensitivity of cells to insulin, is beneficial to more effectively utilizing insulin to reduce blood sugar, has anti-inflammatory properties on components such as inflammation regulation, astragalus and rhizoma polygonati, can reduce chronic inflammation caused by diabetes, blood lipid regulation, poria cocos and the like, is beneficial to regulating the blood lipid level, reduces the risk of cardiovascular diseases, is particularly important in diabetics, has nutrition balance, is beneficial to providing nutrition required for maintaining the whole health of the body, increases the physical strength, improves the immune system function, comprehensively utilizes various components, influences the pathological mechanism of diabetes in a multiple way, and has good use effect on clinical use.
Detailed Description
The technical solutions of the embodiments of the present invention will be clearly and completely described below in conjunction with the embodiments of the present invention, and it is apparent that the described embodiments are only some embodiments of the present invention, not all embodiments. All other embodiments, which can be made by those skilled in the art based on the embodiments of the invention without making any inventive effort, are intended to be within the scope of the invention.
Example 1: the invention provides a traditional Chinese medicine for treating diabetes, and relates to a traditional Chinese medicine for treating diabetes.
The medicine comprises the following components in percentage by weight:
6-20 parts of chicken's gizzard-membrane
12-24 parts of rhizoma anemarrhenae
120-180 parts of balsam pear
Poria cocos 20-30 parts
12-24 parts of Chinese angelica
Hawthorn fruit 18-24 parts
30-60 parts of Chinese yam
Malt 20-30 parts
20-30 parts of kudzuvine root
6-18 parts of ginseng
18-60 parts of astragalus
18-30 parts of rhizoma polygonati, which are mixed according to a specified proportion, are boiled and filtered to form a traditional Chinese medicine liquid, which can be used for treating diabetes mellitus, the traditional Chinese medicine formula influences the pathological mechanism of diabetes mellitus in a plurality of ways, including blood sugar regulation, insulin sensitivity improvement, inflammation regulation, blood fat regulation and comprehensive nutrition support, all herbal medicine components are prepared, prepared and cleaned according to specified parts, the herbal medicine components are mixed together, enough water is added, the mixture is boiled and then stewed for a period of time, the liquid medicine is filtered, and a plurality of components are comprehensively used to influence the pathological mechanism of diabetes mellitus in a plurality of ways, so that the blood sugar is possibly reduced, the insulin sensitivity is improved, the inflammation is regulated, the blood fat level is improved, and the comprehensive nutrition support is provided.
Example 2: the invention provides a traditional Chinese medicine for treating diabetes, and relates to a traditional Chinese medicine for treating diabetes.
The medicine comprises the following components in percentage by weight:
6-20 parts of chicken's gizzard-membrane
12-24 parts of rhizoma anemarrhenae
120-180 parts of balsam pear
Poria cocos 20-30 parts
12-24 parts of Chinese angelica
Hawthorn fruit 18-24 parts
30-60 parts of Chinese yam
Malt 20-30 parts
20-30 parts of kudzuvine root
6-18 parts of ginseng
18-60 parts of astragalus
18-30 parts of rhizoma polygonati,
preparing traditional Chinese medicine components: all the traditional Chinese medicine components are prepared according to the provided weight, carefully cleaned and mixed with the traditional Chinese medicine components: the traditional Chinese medicine components are mixed together to ensure uniform distribution. The mixing ratio is determined according to the amount in the formulation, grinding: grinding the mixed Chinese medicinal materials into powder for subsequent preparation process. This can be done using a professional traditional Chinese medicine grinder to prepare pills: now you can start making pills. This can be accomplished by one of the following means, wet pelleting: mixing the powder with water to form a uniform paste. The paste is then divided into small pieces and then rolled into the shape of a pill. These pills were then air dried and dry-prepared into pills: directly pressing the traditional Chinese medicine powder into pills, using a special pill machine or a tablet press, drying and controlling the quality: the finished pellets were dried in a ventilated place to ensure removal of excess moisture. Before and after drying, quality control inspection is carried out to ensure that the weight and the size of each pill meet the standards, and the package is carried out: packaging the finished pill in packaging material meeting sanitation and quality standards, wherein: radix astragali: middle-jiao invigorating, qi invigorating, vital essence generating, blood nourishing, immunity improving, and rhizoma Polygonati: tonifying qi, nourishing yin, nourishing stomach, tonifying kidney, promoting fluid production, quenching thirst, and poria cocos wolf: dampness-dispelling, spleen-invigorating, heart-nourishing, nerve-soothing, ginseng: greatly invigorating primordial qi, invigorating spleen, nourishing lung, promoting fluid production, nourishing blood, tranquilizing mind, improving intelligence, and enhancing immunity, and malt: spleen invigorating, appetite stimulating, digestion promoting, qi circulation promoting, digestion promoting, rhizoma anemarrhenae: nourishing yin, moistening dryness, clearing heat, purging fire, haw: promoting digestion, reducing blood lipid, softening blood vessel, protecting heart and brain, relieving arteriosclerosis, regulating heart rate, and endothelium corneum Gigeriae Galli: digestion-promoting and stomach-invigorating, diuresis-promoting and calculus-removing balsam pear: regulating blood sugar, clearing heat and detoxicating, chinese angelica: blood replenishing, intestine moistening, constipation relieving, chinese yam: promoting salivation, tonifying kidney, strengthening spleen, eliminating dampness, and radix Puerariae: improving coronary blood supply, promoting salivation, quenching thirst, relieving muscle and yang, reducing blood lipid, relieving fever, invigorating kidney and spleen, and has effects of: repairing pathological islet cells, recovering liver sugar storage function, improving utilization of insulin, repairing liver and kidney injury caused by diabetes, repairing cells, regulating endocrine, relieving fatigue, enhancing immunity, relieving hypertension cells caused by arteriosclerosis, nourishing and repairing, stabilizing blood sugar, and improving various symptoms.
It should be noted that, the foregoing embodiments are only specific and clear descriptions of technical solutions and technical features of the present application. And those skilled in the art will not be able to describe in detail the above embodiments regarding the schemes or features belonging to the prior art or common general knowledge.
In addition, the technical solutions of the present application are not limited to the above-mentioned embodiments, and those skilled in the art should consider the description as a whole, and the technical solutions in the embodiments may be appropriately combined, so as to form other embodiments that can be understood by those skilled in the art.
Claims (2)
1. A Chinese medicine for treating diabetes is characterized by comprising chicken's gizzard-skin, rhizoma anemarrhenae, balsam pear, poria cocos, chinese angelica, hawthorn, chinese yam, malt, kudzuvine root, ginseng, astragalus and rhizoma polygonati.
2. The composition according to claim 1, wherein the ratio of the drugs is as follows:
6-20 parts of chicken's gizzard-membrane
12-24 parts of rhizoma anemarrhenae
120-180 parts of balsam pear
Poria cocos 20-30 parts
12-24 parts of Chinese angelica
Hawthorn fruit 18-24 parts
30-60 parts of Chinese yam
Malt 20-30 parts
20-30 parts of kudzuvine root
6-18 parts of ginseng
18-60 parts of astragalus
18-30 parts of rhizoma polygonati.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202311533259.8A CN117679478A (en) | 2023-11-16 | 2023-11-16 | Traditional Chinese medicine for treating diabetes |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202311533259.8A CN117679478A (en) | 2023-11-16 | 2023-11-16 | Traditional Chinese medicine for treating diabetes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN117679478A true CN117679478A (en) | 2024-03-12 |
Family
ID=90132874
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202311533259.8A Pending CN117679478A (en) | 2023-11-16 | 2023-11-16 | Traditional Chinese medicine for treating diabetes |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN117679478A (en) |
-
2023
- 2023-11-16 CN CN202311533259.8A patent/CN117679478A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1043010C (en) | Spot curing and beautifying preparation | |
| CN107495367A (en) | A kind of food, health products or pharmaceutical composition for improving hypoxia-bearing capability and its production and use | |
| CN104998063A (en) | Anti-fatigue pharmaceutic preparation | |
| CN103623341A (en) | Drug for treating hypertension and cardiovascular and cerebrovascular diseases caused by hypertension | |
| CN101961401B (en) | Compound Chinese medicinal composition having effects of reducing weight, reducing fat, tonifying spleen and beautifying | |
| CN103599215A (en) | Blood sugar-reducing medicament | |
| CN106236833A (en) | A kind of pharmaceutical composition treating cardiovascular and cerebrovascular disease | |
| CN1205974C (en) | Thirty-six ingredients capsule for treating diabetes | |
| CN101461907B (en) | Medicament for treating liver-yang hyperactivity, extinguishing liver-wind and nourishing kidney-yin as well as preparation method | |
| CN102813814B (en) | Traditional Chinese medicine formula for treating hypotension | |
| CN105816750A (en) | Traditional Chinese medicine composition for treating qi-insufficiency constitution and traditional Chinese medicine conditioning paste | |
| CN106692744A (en) | Traditional Chinese medicine composition for treating diabetes mellitus | |
| CN101249255B (en) | Proprietary Chinese medicine for curing children's cough and method of preparing the same | |
| CN117679478A (en) | Traditional Chinese medicine for treating diabetes | |
| CN103599343A (en) | Pharmaceutical composition for treating diabetes, and preparation method and application thereof | |
| CN102600231A (en) | Anti-fatigue nutrient and preparation method thereof | |
| CN1062154C (en) | Method for producing Chinese patent medicine for curing diabetes and its pill | |
| CN105535553A (en) | Formula for regulating blood sugar of human body | |
| CN112023010A (en) | Traditional Chinese medicine composition for slimming, preparation method thereof, oral medicine and application | |
| CN114588228B (en) | Composition for treating type 2 diabetes | |
| CN103919972B (en) | A kind of pharmaceutical composition of resisting fatigue and its preparation method and application | |
| CN1168483C (en) | Heart disease treating medicine | |
| CN110755504A (en) | Traditional Chinese medicine preparation for nourishing yin and blood and preparation method thereof | |
| CN101618071B (en) | Compound radix salviae miltiorrhizae film slow-release tablet and preparation method thereof | |
| CN103585435A (en) | Pharmaceutical composition for treating diabetes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |